Genentech Brings Marketing Back To Senior Management: Potter To COO
Executive Summary
Genentech is bringing big pharma sales and marketing expertise back into its senior management structure with the appointment of former Bristol-Myers Squibb exec Myrtle Potter as chief operating officer and exec VP-commercial operations.
You may also be interested in...
Genentech Research To Be Headed By Stanford Scientist Scheller
Genentech has chosen Stanford scientist Richard Scheller, PhD, to succeed Dennis Henner, PhD, as head of research.
Genentech Research To Be Headed By Stanford Scientist Scheller
Genentech has chosen Stanford scientist Richard Scheller, PhD, to succeed Dennis Henner, PhD, as head of research.
Bristol Vanlev Launch Resources Will Shift To Pravachol; NDA Withdrawn
Bristol plans to reallocate some of the money reserved for the launch of the antihypertensive Vanlev to help revive the cholesterol-lowering agent Pravachol.